BlackRock Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$92K Sell
7,387
-32
-0.4% -$381 ﹤0.01% 3064
2016
Q3
$103K Buy
7,419
+951
+15% +$10.8K ﹤0.01% 3004
2016
Q2
$64K Buy
6,468
+459
+8% +$7.61K ﹤0.01% 3155
2016
Q1
$102K Hold
6,009
﹤0.01% 2906
2015
Q4
$134K Sell
6,009
-2,537
-30% -$64K ﹤0.01% 2786
2015
Q3
$202K Sell
8,546
-3,158
-27% -$198K ﹤0.01% 2722
2015
Q2
$957K Buy
11,704
+7,102
+154% +$695K ﹤0.01% 1692
2015
Q1
$426K Buy
4,602
+1,366
+42% +$88.2K ﹤0.01% 2189
2014
Q4
$131K Buy
3,236
+598
+23% +$18.3K ﹤0.01% 2889
2014
Q3
$65K Sell
2,638
-601
-19% -$9.55K ﹤0.01% 3201
2014
Q2
$51K Sell
3,239
-853
-21% -$12.3K ﹤0.01% 3254
2014
Q1
$62K Sell
4,092
-987
-19% -$15.3K ﹤0.01% 3198
2013
Q4
$70K Sell
5,079
-113,667
-96% -$1.65M ﹤0.01% 3164
2013
Q3
$2.24M Buy
+118,746
New +$1.99M ﹤0.01% 1138

Other funds holding ESPR